AbbVie, a global, research-based biopharmaceutical company, is dedicated to supporting the search for a cure.
Born and raised in a small town in Mississippi, Jonathan Lawler always dreamed of going to New York City. So when the 19-year-old junior college student was invited to visit the Big Apple as part of a special delegation, he jumped at the opportunity.
Jonathan, who has CF, did more than just take in the sights. He, along with other patients, executives and employees from more than 40 countries, helped celebrate the launch of a new biopharmaceutical company — AbbVie — by ringing the opening bell at the New York Stock Exchange on January 2.
For Jonathan, it was the experience of a lifetime.
“It was total culture shock. I didn’t know how much actually went in to making the stock market function. Everyone was just running around — there wasn’t a single person there standing still,” Jonathan said. “I’m so thankful AbbVie invited me to be part of the experience.”
A Legacy of Commitment
This year, AbbVie, a global, research-based biopharmaceutical company, will sponsor more than 600 Great Strides walks throughout the nation. The corporation is focused on its patients and committed to developing therapies for life-threatening diseases, including cystic fibrosis.
AbbVie is an independent, global, research-based biopharmaceutical company composed of Abbott’s former proprietary pharmaceutical business. AbbVie aims to develop advanced therapies for life-threatening diseases — including cystic fibrosis.
back to top
Although AbbVie is a new company with a new name, its focus remains on patients. The company supports the CF community and is a premier national sponsor of the Cystic Fibrosis Foundation’s Great Strides fundraising walks.
“We are proud of our more than 20-year relationship with the Cystic Fibrosis Foundation and our support of Foundation programs and initiatives,” said Jim Hynd, divisional vice president, Cardiovascular Care, Metabolics and GI Care at AbbVie. “As a company, we are engaged in ongoing support for the CF community via nutritional, financial and educational efforts.”
This year, AbbVie will sponsor more than 600 Great Strides walks across the nation and has committed more than $600,000 to the Foundation through sponsorship and other fundraising efforts. Starting in May, employees of the company will lace up their shoes and join in the festivities, walking in events throughout the country. But AbbVie doesn’t just limit itself to Great Strides. Year round, AbbVie employees can be found supporting CF Foundation events throughout the United States.
“AbbVie supports the CF community at every level. We are extremely grateful to have such a dedicated partner in our search for a cure,” said C. Richard Mattingly, Foundation executive vice president and chief operating officer. “As Abbott, this company has helped make possible tremendous breakthroughs in CF research and care over the past two decades. We look forward to continuing that legacy with AbbVie as we accelerate our search for a cure.”
Going Above and Beyond
AbbVie offers a variety of resources to support the CF community and currently provides comprehensive nutritional and financial resources to patients and their families at no cost through the CFCareForward program.
Additionally, since 1993, the company has offered an educational scholarship that has awarded $2.3 million in educational funding to more than 500 students with CF pursuing higher education. For people like Jonathan, AbbVie’s commitment to the CF community is priceless. He’s using his experience in New York to kick start a new dream — raising wider awareness about CF.
“Everything AbbVie does emphasizes the fact that the company and its employees are working for their patients,” Jonathan said. “What they do helps others live better lives and I want to do the same.”